XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Series A redeemable convertible preferred shares
Series A+ redeemable convertible preferred shares
Series B redeemable convertible preferred stock
Series B1 redeemable convertible preferred stock
Ordinary shares
Ordinary shares
Non-voting ordinary shares
Ordinary shares
Non-voting ordinary shares
Ordinary shares
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Beginning balance at Dec. 31, 2021 $ 32,001 $ 26,000 $ 100,000 $ 8,959                
Beginning balance (in shares) at Dec. 31, 2021 19,200,000 12,800,000 24,702,000 2,161,000                
Ending balance at Mar. 31, 2022 $ 32,001 $ 26,000 $ 100,000 $ 8,959                
Ending balance (in shares) at Mar. 31, 2022 19,200,000 12,800,000 24,702,000 2,161,000                
Beginning balance at Dec. 31, 2021               $ 1     $ (64,736) $ (64,735)
Beginning balance (in shares) at Dec. 31, 2021               10,894,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Share-based compensation expense                 $ 620     620
Unrealized loss on investments, net                   $ (35)   (35)
Net loss                     (13,081) (13,081)
Ending balance at Mar. 31, 2022               $ 1 620 (35) (77,817) (77,231)
Ending balance (in shares) at Mar. 31, 2022               10,894,000        
Beginning balance at Dec. 31, 2021 $ 32,001 $ 26,000 $ 100,000 $ 8,959                
Beginning balance (in shares) at Dec. 31, 2021 19,200,000 12,800,000 24,702,000 2,161,000                
Ending balance at Jun. 30, 2022 $ 32,001 $ 26,000 $ 133,015 $ 8,959                
Ending balance (in shares) at Jun. 30, 2022 19,200,000 12,800,000 32,857,000 2,161,000                
Beginning balance at Dec. 31, 2021               $ 1     (64,736) (64,735)
Beginning balance (in shares) at Dec. 31, 2021               10,894,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Unrealized loss on investments, net                       (85)
Net loss                       (27,029)
Ending balance at Jun. 30, 2022               $ 1 641 (85) (92,660) (92,103)
Ending balance (in shares) at Jun. 30, 2022               10,452,000        
Beginning balance at Mar. 31, 2022 $ 32,001 $ 26,000 $ 100,000 $ 8,959                
Beginning balance (in shares) at Mar. 31, 2022 19,200,000 12,800,000 24,702,000 2,161,000                
Increase (Decrease) in Temporary Equity [Roll Forward]                        
Issuance of redeemable convertible preferred shares, net of issuance costs     $ 31,500                  
Accretion of redeemable convertible preferred shares to their redemption value     1,515                  
Ending balance at Jun. 30, 2022 $ 32,001 $ 26,000 $ 133,015 $ 8,959                
Ending balance (in shares) at Jun. 30, 2022 19,200,000 12,800,000 32,857,000 2,161,000                
Beginning balance at Mar. 31, 2022               $ 1 620 (35) (77,817) (77,231)
Beginning balance (in shares) at Mar. 31, 2022               10,894,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Accretion of redeemable convertible preferred shares to their redemption value                 620   895 1,515
Repurchase of unvested restricted share awards                 (6)     (6)
Repurchase of unvested restricted share awards (in shares)               (450,000)        
Issuance of ordinary shares upon exercise of vested share options                 4     4
Issuance of ordinary shares upon exercise of vested share options (in shares)               8,000        
Share-based compensation expense                 643     643
Unrealized loss on investments, net                   (50)   (50)
Net loss                     (13,948) (13,948)
Ending balance at Jun. 30, 2022               $ 1 641 (85) (92,660) $ (92,103)
Ending balance (in shares) at Jun. 30, 2022               10,452,000        
Increase (Decrease) in Temporary Equity [Roll Forward]                        
Issuance of redeemable convertible preferred shares, net of issuance costs (in shares)     8,155,000                  
Beginning balance at Dec. 31, 2022 $ 32,001 $ 26,000 $ 133,015 $ 8,959                
Beginning balance (in shares) at Dec. 31, 2022 19,200,000 12,799,681 32,857,004 2,161,402               67,018,087
Increase (Decrease) in Temporary Equity [Roll Forward]                        
Conversion of redeemable convertible preferred shares into ordinary shares upon initial public offering (in Shares) (19,200,000) (12,800,000) (32,857,000) (2,161,000)                
Conversion of redeemable convertible preferred shares into ordinary shares upon initial public offering $ (32,001) $ (26,000) $ (133,015) $ (8,959)                
Beginning balance at Dec. 31, 2022         $ 1       1,921 (110) (116,952) $ (115,140)
Beginning balance (in shares) at Dec. 31, 2022         10,527,000              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Conversion of redeemable convertible preferred shares into ordinary shares upon initial public offering         $ 7       199,968     199,975
Conversion of redeemable convertible preferred shares into ordinary shares upon initial public offering (in Shares)         67,018,000              
Issuance of ordinary shares upon initial public offering, net of issuance costs and underwriting discount         $ 3       166,667     166,670
Issuance of ordinary shares upon initial public offering, net of issuance costs and underwriting discount (in shares)         37,053,000              
Net exercise of ordinary share warrants (in Shares)         106,000              
Issuance of ordinary shares upon exercise of vested share options                 31     31
Issuance of ordinary shares upon exercise of vested share options (in shares)         26,000              
Share-based compensation expense                 2,533     2,533
Unrealized loss on investments, net                   257   257
Net loss                     (17,975) (17,975)
Ending balance at Mar. 31, 2023         $ 11       371,120 147 (134,927) $ 236,351
Ending balance (in shares) at Mar. 31, 2023         114,730,000              
Beginning balance at Dec. 31, 2022 $ 32,001 $ 26,000 $ 133,015 $ 8,959                
Beginning balance (in shares) at Dec. 31, 2022 19,200,000 12,799,681 32,857,004 2,161,402               67,018,087
Ending balance (in shares) at Jun. 30, 2023 0 0 0 0                
Beginning balance at Dec. 31, 2022         $ 1       1,921 (110) (116,952) $ (115,140)
Beginning balance (in shares) at Dec. 31, 2022         10,527,000              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of ordinary shares upon initial public offering, net of issuance costs and underwriting discount (in shares)             7,410,518          
Issuance of ordinary shares upon exercise of vested share options (in shares)                       94,000
Unrealized loss on investments, net                       $ (280)
Net loss                       (41,255)
Ending balance at Jun. 30, 2023         $ 10 $ 1     373,001 (390) (158,207) 214,415
Ending balance (in shares) at Jun. 30, 2023         107,387,000 7,411,000            
Ending balance (in shares) at Jun. 30, 2023 0 0 0 0                
Beginning balance at Mar. 31, 2023         $ 11       371,120 147 (134,927) 236,351
Beginning balance (in shares) at Mar. 31, 2023         114,730,000              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Exchange of ordinary shares to non-voting ordinary shares         $ (1) $ 1            
Exchange of ordinary shares to non-voting ordinary shares (in shares)         (7,411,000) 7,411,000            
Issuance of ordinary shares upon exercise of vested share options                 179     179
Issuance of ordinary shares upon exercise of vested share options (in shares)         68,000              
Share-based compensation expense                 1,702     1,702
Unrealized loss on investments, net                   (537)   (537)
Net loss                     (23,280) (23,280)
Ending balance at Jun. 30, 2023         $ 10 $ 1     $ 373,001 $ (390) $ (158,207) $ 214,415
Ending balance (in shares) at Jun. 30, 2023         107,387,000 7,411,000